Sonark Pharmaceutical Private Limited
About Sonark Pharmaceutical Private Limited
Data last updated:
Sonark Pharmaceutical Private Limited is a private limited company based in Satara, Maharashtra, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 19 October 1988 and has been in existence for over 38 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24232MH1988PTC049307. Its GSTIN is 27AADCS7786B1Z4 (Maharashtra).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors including Girish Sudhakar Soman and Devendra Girish Soman.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aushadh Nirmanbhavan Plot No. J – 13/17 Additional MIDC, Satara, Maharashtra, India – 415004.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.15 Cr, a growth of 25% compared to the previous year. For the same year it recorded a net profit of ₹7.33 Lakh (net margin 6.3%) and EBITDA of ₹15.05 Lakh (EBITDA margin 13%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 4% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹75 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sonark Pharmaceutical Private Limited's registered office is in Satara, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAushadh Nirmanbhavan Plot No. J – 13/17 Additional MIDC, Satara, Maharashtra, India – 415004
- IndustryHealthcare, Ayurvedic Products & Services
To see the full contact details of Sonark Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sonark Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Sonark Pharmaceutical Private Limited, buy the company report.
Financials of Sonark Pharmaceutical Private Limited
FY 2025 filings availableSonark Pharmaceutical Private Limited reported revenue of ₹1.15 Cr (up 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 25% growth in the latest year. EBITDA rose 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹15.05 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13% | ||||
| Net Profit Margin | 6.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sonark Pharmaceutical Private Limited, buy the company report.
Board of directors of Sonark Pharmaceutical Private Limited
Sonark Pharmaceutical has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Sudhakar Soman Also directs: World Neem Organisation, Tru-Uth DMK India Private Limited, Nisarga Biotech Private Limited and 4 more | Director | 14 Dec 2009 | 16 Years 10 Months | Current |
| Devendra Girish Soman Also directs: Tru-Uth DMK India Private Limited, Nisarga Biotech Private Limited, Nuaxon Innovations Private Limited and 1 more | Director | 23 Feb 2022 | 4 Years 7 Months | Current |
| Tanmay Girish Soman | Director | 23 Feb 2022 | 4 Years 7 Months | Current |
| Arati Devendra Soman Also directs: Nisarga Biotech Private Limited | Director | 29 Sep 2023 | 3 Years 0 Months | Current |
Auditor
Sonark Pharmaceutical Private Limited is audited by SWAPNIL K. BACHUTE & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SWAPNIL K. BACHUTE & CO. | FY 2023 | 130448W |
Shareholding
The shareholding of Sonark Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sonark Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Oct 2015 | 10602008 | Idbi Bank Limited | ₹17 Lakh | Open | |
| 04 Sep 2010 | 10299100 | Idbi Bank Limited | ₹58 Lakh | Open |
To see the full charge records of Sonark Pharmaceutical Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Sonark Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Sonark Pharmaceutical Private Limited has 5 MSME Form 1 returns on record between 2019 and 2022, listing 49 overdue payments to 11 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 11)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Amsar Private Limited | |||
| Perfect Plasitc | |||
| an individual supplier | |||
| Santosh Ayurvedic Drug Supply Co. |
To see the full MSME payment records of Sonark Pharmaceutical Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Sonark Pharmaceutical has 5 associated companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
Employees & EPFO
Sonark Pharmaceutical Private Limited has a workforce of 15 employees on its EPFO records as of Nov 29, 2024, across 1 active EPFO establishment.
GST
Sonark Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCS7786B1Z4 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sonark Pharmaceutical Private Limited, buy the company report.
Recent activity
Sonark Pharmaceutical Private Limited has 26 board changes on record since 1988: 15 appointments and 11 cessations. The latest: Jalindar Shrirang Shinde ceased to be Director on 01 Jan 2026.
20 earlier events are in the company report.
Frequently asked questions
Sonark Pharmaceutical is an active private limited company based in Satara, Maharashtra, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 19 October 1988 (38+ years old) and is registered under CIN U24232MH1988PTC049307.
Sonark Pharmaceutical has 4 current directors:
- Girish Sudhakar Soman - Director
- Devendra Girish Soman - Director
- Tanmay Girish Soman - Director
- Arati Devendra Soman - Director
The latest financial statements of Sonark Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sonark Pharmaceutical is 27AADCS7786B1Z4, registered in Maharashtra.
The CIN (Corporate Identification Number) of Sonark Pharmaceutical is U24232MH1988PTC049307. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sonark Pharmaceutical was incorporated on 19 October 1988, making it 38+ years old. It is registered with the Registrar of Companies, Pune.
Jalindar Shrirang Shinde ceased to be Director on 01 Jan 2026. Renuka Shantanu Shinde ceased to be Director on 01 Jan 2026. Shantanu Jalindar Shinde ceased to be Director on 01 Jan 2026. Sonark Pharmaceutical has 26 board changes on record in total.
Sonark Pharmaceutical has 5 MSME Form 1 returns on record between 2019 and 2022, listing 49 overdue payments to 11 micro and small suppliers. The latest return was filed on 30 Apr 2022.
The registered office of Sonark Pharmaceutical is at Aushadh Nirmanbhavan Plot No. J – 1317 Additional MIDC, Satara, Maharashtra, India – 415004.
Sonark Pharmaceutical operates in the healthcare industry, in the ayurvedic products and services segment.
Sonark Pharmaceutical has open charges of ₹75 Lakh and no satisfied charges on record as per latest MCA filings.